Curalogic AS
Industry
- Biotechnology
- Pharmaceuticals
- Drug Delivery
Latest on Curalogic AS
Cytochroma, a clinical-stage speciality pharmaceutical company, has appointed Dr Peter Moldt to its board of directors. He is a partner in Novo A/S, part of the Novo Nordisk Foundation, which he joine
Curalogic 's board of directors has recommended that the company be liquidated after it failed to secure any new development projects. The company was in talks with seven Danish and foreign biotech c
Two top executives at the Danish pharmaceutical company Curalogic have resigned, as the company looks likely to go into liquidation. CEO Peter Moldt and CFO Helle Busck Fenavig will stay on until
In Vitro Diagnostics Acquisitions bioMerieux SA Trinity Biotech PLC For approximately €76.8mm ($60mm) (including assets, fees, and earn-outs), bioMerieux has sold its hemostasis product line to diag